CHD1L and neoplasm: Moreover, epithelial tumor-free survival tended to be slightly increased for mice lacking ALC1, with a median survival of 741 days for Alc1−/− compared to 695 days for Alc1+/+ (Figure S1J, left panel) accompanied by a mild decrease in the number of Alc1−/− mice developing one or more than one tumor (Figure S1J, middle and right panel).